A Trademark

Trademark Overview

On Wednesday, November 16, 2016, a trademark application was filed for A with the United States Patent and Trademark Office. The USPTO has given the A trademark a serial number of 79201245. The federal status of this trademark filing is SECTION 71 ACCEPTED as of Friday, June 28, 2024. This trademark is owned by Adverum Biotechnologies, Inc.. The A trademark is filed in the Pharmaceutical Products category with the following description:

PHARMACEUTICAL PREPARATIONS FOR USE IN GENE THERAPY FOR THE TREATMENT OF OSTEOARTHRITIS, NEUROLOGIC CONDITIONS, INFLAMMATORY CONDITIONS, IMMUNE-MEDIATED CONDITIONS, ENDOCRINE DISEASES, CHRONIC DEGENERATIVE DISEASES, GASTROINTESTINAL DISEASES; PHARMACEUTICAL PREPARATIONS FOR GENE THERAPY FOR THE TREATMENT OF GENETIC DISEASES OR DISORDERS; PHARMACEUTICAL PREPARATIONS FOR USE IN THE TREATMENT OF GENE THERAPY TREATABLE DISEASES, NAMELY, OSTEOARTHRITIS, NEUROLOGIC CONDITIONS, INFLAMMATORY CONDITIONS, IMMUNE-MEDIATED CONDITIONS, ENDOCRINE DISEASES, CHRONIC DEGENERATIVE DISEASES, GASTROINTESTINAL DISEASES; PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF DISORDERS OF THE NERVOUS SYSTEM, THE IMMUNE SYSTEM, THE CARDIO-VASCULAR SYSTEM, THE METABOLIC SYSTEM, THE RESPIRATORY SYSTEM, THE MUSCULO-SKELETAL SYSTEM, THE OCULAR AND AUDITORY SYSTEMS, AND THE GENITOURINARY SYSTEM
a

General Information

Serial Number79201245
Word MarkA
Filing DateWednesday, November 16, 2016
Status706 - SECTION 71 ACCEPTED
Status DateFriday, June 28, 2024
Registration Number5488639
Registration DateTuesday, June 12, 2018
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, March 27, 2018

Trademark Statements

Description of MarkThe mark consists of a stylized letter "A" with a shaded circle to the right of the letter.
Goods and ServicesPHARMACEUTICAL PREPARATIONS FOR USE IN GENE THERAPY FOR THE TREATMENT OF OSTEOARTHRITIS, NEUROLOGIC CONDITIONS, INFLAMMATORY CONDITIONS, IMMUNE-MEDIATED CONDITIONS, ENDOCRINE DISEASES, CHRONIC DEGENERATIVE DISEASES, GASTROINTESTINAL DISEASES; PHARMACEUTICAL PREPARATIONS FOR GENE THERAPY FOR THE TREATMENT OF GENETIC DISEASES OR DISORDERS; PHARMACEUTICAL PREPARATIONS FOR USE IN THE TREATMENT OF GENE THERAPY TREATABLE DISEASES, NAMELY, OSTEOARTHRITIS, NEUROLOGIC CONDITIONS, INFLAMMATORY CONDITIONS, IMMUNE-MEDIATED CONDITIONS, ENDOCRINE DISEASES, CHRONIC DEGENERATIVE DISEASES, GASTROINTESTINAL DISEASES; PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF DISORDERS OF THE NERVOUS SYSTEM, THE IMMUNE SYSTEM, THE CARDIO-VASCULAR SYSTEM, THE METABOLIC SYSTEM, THE RESPIRATORY SYSTEM, THE MUSCULO-SKELETAL SYSTEM, THE OCULAR AND AUDITORY SYSTEMS, AND THE GENITOURINARY SYSTEM
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, February 10, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAdverum Biotechnologies, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressUS
Party NameAdverum Biotechnologies, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressUS
Party NameAdverum Biotechnologies, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressUS

Trademark Events

Event DateEvent Description
Tuesday, February 14, 2017APPLICATION FILING RECEIPT MAILED
Thursday, February 9, 2017SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, February 10, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, February 22, 2017ASSIGNED TO EXAMINER
Wednesday, February 22, 2017NON-FINAL ACTION WRITTEN
Thursday, February 23, 2017NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, February 27, 2017REFUSAL PROCESSED BY MPU
Monday, February 27, 2017NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, March 18, 2017REFUSAL PROCESSED BY IB
Friday, August 18, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, August 18, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, August 28, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, August 28, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, August 28, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 29, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, September 14, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, September 14, 2017FINAL REFUSAL WRITTEN
Thursday, September 14, 2017FINAL REFUSAL E-MAILED
Thursday, September 14, 2017NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, February 20, 2018TEAS REQUEST FOR RECONSIDERATION RECEIVED
Tuesday, February 20, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 21, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, February 22, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 7, 2018NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, March 7, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, March 7, 2018NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Saturday, March 24, 2018NOTIFICATION PROCESSED BY IB
Tuesday, March 27, 2018PUBLISHED FOR OPPOSITION
Tuesday, March 27, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 12, 2018REGISTERED-PRINCIPAL REGISTER
Wednesday, September 12, 2018FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Thursday, September 20, 2018FINAL DISPOSITION PROCESSED
Friday, September 21, 2018FINAL DISPOSITION NOTICE SENT TO IB
Friday, October 12, 2018FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, January 20, 2023NEW REPRESENTATIVE AT IB RECEIVED
Saturday, February 4, 2023CHANGE OF NAME/ADDRESS REC'D FROM IB
Monday, June 12, 2023COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, September 29, 2023TEAS SECTION 71 RECEIVED
Tuesday, May 21, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, June 28, 2024REGISTERED-SEC.71 ACCEPTED
Friday, June 28, 2024NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED

Related Keywords

diseases system conditions pharmaceutical preparations treatment therapy gene immune chronic